MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 91 filers reported holding MYOVANT SCIENCES LTD in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $912,030 | +47.8% | 33,829 | -1.5% | 0.00% | – |
Q3 2022 | $617,000 | +1.1% | 34,349 | -30.0% | 0.00% | – |
Q2 2022 | $610,000 | +63.5% | 49,046 | +74.8% | 0.00% | – |
Q1 2022 | $373,000 | -12.9% | 28,061 | +2.2% | 0.00% | – |
Q4 2021 | $428,000 | -30.5% | 27,469 | 0.0% | 0.00% | – |
Q3 2021 | $616,000 | +33.3% | 27,469 | +35.4% | 0.00% | – |
Q2 2021 | $462,000 | +10.5% | 20,291 | 0.0% | 0.00% | – |
Q1 2021 | $418,000 | +1166.7% | 20,291 | +1622.5% | 0.00% | – |
Q4 2020 | $33,000 | -5.7% | 1,178 | -52.7% | 0.00% | – |
Q3 2020 | $35,000 | -31.4% | 2,490 | 0.0% | 0.00% | – |
Q2 2020 | $51,000 | +168.4% | 2,490 | 0.0% | 0.00% | – |
Q1 2020 | $19,000 | -51.3% | 2,490 | 0.0% | 0.00% | – |
Q4 2019 | $39,000 | +1200.0% | 2,490 | +367.2% | 0.00% | – |
Q3 2019 | $3,000 | -40.0% | 533 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | -61.5% | 533 | 0.0% | 0.00% | – |
Q1 2019 | $13,000 | +44.4% | 533 | 0.0% | 0.00% | – |
Q4 2018 | $9,000 | -52.6% | 533 | -67.2% | 0.00% | – |
Q1 2017 | $19,000 | -5.0% | 1,626 | 0.0% | 0.00% | – |
Q4 2016 | $20,000 | – | 1,626 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 142,065 | $2,924,000 | 4.61% |
Tri Locum Partners LP | 321,101 | $6,608,000 | 1.64% |
PFM Health Sciences, LP | 2,054,928 | $42,290,000 | 1.29% |
Bellevue Group AG | 5,194,039 | $106,893,000 | 1.13% |
Pier Capital, LLC | 554,779 | $11,417,000 | 1.08% |
Opaleye Management Inc. | 249,800 | $5,141,000 | 0.76% |
Evolution Wealth Advisors, LLC | 140,227 | $2,886,000 | 0.64% |
Hennion & Walsh Asset Management, Inc. | 399,330 | $8,218,000 | 0.49% |
Cormorant Asset Management, LP | 1,000,000 | $20,580,000 | 0.46% |
Integral Health Asset Management, LLC | 65,000 | $1,338,000 | 0.38% |